v3.26.1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Summary of Potential Dilutive Securities Excluded from Calculation of Diluted Per Share

The following equity instruments were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:

 

 

March 31,

 

 

 

2026

 

 

2025

 

Stock options, issued and outstanding

 

 

8,202,603

 

 

 

8,392,094

 

Estimated shares issuable under the ESPP

 

 

173,695

 

 

 

41,710

 

Restricted stock subject to future vesting

 

 

857,500

 

 

 

 

Common warrants to purchase common stock

 

 

37,024,389

 

 

 

 

Total

 

 

46,258,187

 

 

 

8,433,804